Royal Bank of Canada set a $68.00 price objective on Express Scripts (NASDAQ:ESRX) in a research report sent to investors on Friday morning. The brokerage currently has a hold rating on the stock.

Several other research analysts have also recently issued reports on ESRX. Jefferies Group set a $72.00 target price on shares of Express Scripts and gave the stock a buy rating in a report on Tuesday, August 29th. Robert W. Baird reiterated a hold rating and issued a $56.00 price target on shares of Express Scripts in a research note on Friday, September 1st. ValuEngine lowered shares of Express Scripts from a buy rating to a hold rating in a research note on Friday, September 1st. UBS lowered shares of Express Scripts from a market perform rating to an underperform rating in a research note on Monday, October 9th. Finally, Raymond James Financial reiterated an underperform rating on shares of Express Scripts in a research note on Monday, October 9th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of Hold and an average price target of $74.40.

Shares of Express Scripts (ESRX) traded up $2.53 during trading on Friday, reaching $71.55. 8,786,136 shares of the company’s stock traded hands, compared to its average volume of 4,094,484. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. The stock has a market capitalization of $39,091.06, a PE ratio of 10.09, a PEG ratio of 1.02 and a beta of 0.88. Express Scripts has a twelve month low of $55.80 and a twelve month high of $73.42.

Express Scripts (NASDAQ:ESRX) last issued its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.90. The business had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.74 earnings per share. research analysts forecast that Express Scripts will post 7.01 earnings per share for the current fiscal year.

In related news, VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Timothy C. Wentworth bought 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. Insiders own 0.68% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in ESRX. Capital Asset Advisory Services LLC bought a new position in shares of Express Scripts in the second quarter worth approximately $312,000. Factory Mutual Insurance Co. boosted its position in shares of Express Scripts by 2.4% in the second quarter. Factory Mutual Insurance Co. now owns 766,488 shares of the company’s stock worth $48,933,000 after purchasing an additional 18,000 shares during the period. Atria Investments LLC boosted its position in shares of Express Scripts by 53.1% in the second quarter. Atria Investments LLC now owns 9,431 shares of the company’s stock worth $602,000 after purchasing an additional 3,270 shares during the period. Private Trust Co. NA boosted its position in shares of Express Scripts by 13.8% in the second quarter. Private Trust Co. NA now owns 11,351 shares of the company’s stock worth $724,000 after purchasing an additional 1,378 shares during the period. Finally, Confluence Investment Management LLC boosted its position in shares of Express Scripts by 9.5% in the second quarter. Confluence Investment Management LLC now owns 372,228 shares of the company’s stock worth $23,763,000 after purchasing an additional 32,207 shares during the period. Institutional investors own 88.44% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/express-scripts-esrx-given-a-68-00-price-target-by-royal-bank-of-canada-analysts/1768320.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.